Skip to main content
Equibles

COMMERCE BANK

Bank

Position in CBUS — Cibus, Inc.

CIK 1009076 KANSAS CITY, MO
Back to CBUS Full portfolio

Position in CBUS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$28,085
-$12,505 QoQ
Shares Held
20,500
0.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 62 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CBUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

COMMERCE BANK holds $32,396,174 across 26 Biotechnology names. CBUS ranks #24 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 7,131 $4,446,463
2 EXEL
Exelixis, Inc.
 78,937 $4,294,961
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 8,033 $3,990,231
4 MRNA
Moderna, Inc.
 55,243 $3,868,667
5 ALNY
Alnylam Pharmaceuticals, Inc.
 9,461 $2,848,043
6 TECH
BIO-TECHNE Corp
 33,609 $2,374,475
7 INCY
Incyte Corp
 20,084 $2,276,721
8 HALO
Halozyme Therapeutics, Inc.
 17,206 $1,346,712

All Filings in CBUS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,085 20,500
2026-03-31 $40,590 20,500